Transplant Rejection
📧 Sign up to get email alerts when something new happens for Transplant Rejection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: BIVV020 (SAR445088) in Prevention and Treatment of Antibody-mediated Rejection (AMR) [Phase 2]
A Phase 2 clinical trial investigating BIVV020 (SAR445088) for preventing and treating antibody-mediated rejection in transplant recipients …
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: VEL-101 to Prevent Rejection After Kidney Transplantation [Phase 2]
VEL-101 is being studied in a Phase 2 trial to prevent rejection in kidney transplant recipients; the study is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2018-05-08Clinical Trial Update: Generic Mycophenolate Mofetil Safety Study for Prophylaxis in de Novo Renal Transplant Patients in Jordan
This clinical trial update reports completion of a safety study evaluating generic mycophenolate mofetil as prophylaxis against acute reject…
-
CLINICAL_TRIALS trial_result · 2016-12-23Clinical Trial Update: Study of Glycemic Control on Liver Transplantation Outcomes [Phase 4]
A Phase 4 clinical trial from Northwestern University evaluated whether glycemic control affects liver transplantation outcomes, including h…
-
CLINICAL_TRIALS trial_result · 2016-09-30Clinical Trial Update: Study of Tolerant Kidney Transplant Recipients
The clinical trial evaluating tolerance in kidney transplant recipients has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-07-21Clinical Trial Update: Safety, Tolerability, PK, PD, and Immunogenicity of Single and Multiple Ascending Intravenous Doses of FR104 [Phase 1]
Phase 1 study of FR104 (intravenous) in rheumatoid arthritis and transplant complications assessing safety, tolerability, PK/PD, and immunog…
-
FDA approval · 2015-10-30FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s supplemental application for mycophenolate mofetil, enabling generic manufacturing and marketi…
-
CLINICAL_TRIALS trial_result · 2015-03-23Clinical Trial Update: Efficacy and Safety of Induction Strategies Combined With Low Tacrolimus Exposure in Kidney Transplant Recipients Receiving Everolimus or Sodium Mycophenolate [Phase 4]
Phase 4 trial assessing induction strategies with low tacrolimus exposure in kidney transplant patients treated with everolimus or mycopheno…
-
CLINICAL_TRIALS trial_result · 2015-03-05Clinical Trial Update: Montelukast in Bronchiolitis Obliterans Syndrome [Phase 4]
A Phase 4 clinical trial evaluating montelukast in bronchiolitis obliterans syndrome after lung transplantation has completed. The study als…
-
CLINICAL_TRIALS trial_result · 2014-06-27Clinical Trial Update: Study to Evaluate Effect of Belatacept on Pharmacokinetics of Inje Cocktail in Healthy Volunteers [Phase 4]
Phase 4 study evaluating whether belatacept affects the pharmacokinetics of an Inje Cocktail in healthy volunteers; results were posted in 2…
-
CLINICAL_TRIALS trial_result · 2013-10-25Clinical Trial Update: A Trial of Two Daclizumab Dosing Strategies vs. No Induction Treatment With Tacrolimus, Mycophenolate Mofetil , & Steroids for the Prevention of Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients [Phase 4]
Phase 4 trial comparing two daclizumab dosing strategies to no induction therapy with tacrolimus, mycophenolate mofetil, and steroids to pre…
-
CLINICAL_TRIALS trial_result · 2012-02-29Clinical Trial Update: Study To Evaluate Pharmacokinetics Of Sirolimus In Stable Renal Transplant Recipients [Phase 1]
Phase 1 trial update reporting pharmacokinetics of sirolimus in stable renal transplant recipients; results were posted in 2012.